Eris Lifesciences Limited IPO (ERIS)
Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.
Brokerage-free equity & mutual fund investments
Trade with Zerodha's Kite platform and tools.
- Zero brokerage on equity delivery
- ₹20 flat for intraday, F&O, currency and commodity*
- Free direct mutual fund investing
Flat ₹20 per order, every segment
Trade stocks, derivatives and more on 5paisa's platform.
- ₹20 flat for delivery, intraday and F&O
- Free account opening
- Listed on NSE and BSE
Frequently asked questions
What is the price band for the Eris Lifesciences Limited IPO?
The Eris Lifesciences Limited IPO price band is Rs 600 to Rs 603 per share.
When does the Eris Lifesciences Limited IPO open and close?
Bidding opens 16 June 2017 and closes 20 June 2017.
Is the Eris Lifesciences Limited IPO a mainboard or SME issue?
Eris Lifesciences Limited is a mainboard IPO, listing on NSE's main board.
When did the Eris Lifesciences Limited IPO list?
Eris Lifesciences Limited listed on 29 June 2017.
Does this page show the grey market premium (GMP) for Eris Lifesciences Limited?
No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.
Is investing in the Eris Lifesciences Limited IPO recommended by BrokerLens?
No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.